GNH USA

Europe — EMA

Levomepromazine Maleate Morningside Healthcare

GNH USA supplies Levomepromazine Maleate Morningside Healthcare (Levomepromazine Maleate), a phenothiazine antipsychotic for schizophrenia, psychotic

Levomepromazine Maleate

Request sourcing

1
Pack/s

What is Levomepromazine Maleate?

Levomepromazine Maleate, the active ingredient in Levomepromazine Maleate Morningside Healthcare, is a phenothiazine antipsychotic presented as an oral formulation for oral use. It is employed to manage schizophrenia, other psychotic disorders, and severe nausea or vomiting that does not respond to conventional therapy.

GNH USA supplies Levomepromazine Maleate Morningside Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Levomepromazine Maleate used for?

Levomepromazine Maleate is used within the phenothiazine antipsychotic class to treat several serious conditions.

- Schizophrenia: reduces psychotic symptoms such as delusions and hallucinations. - Psychotic disorders: controls acute agitation and behavioral disturbances. - Severe nausea and vomiting: provides antiemetic relief when other agents are ineffective.

What are the side effects of Levomepromazine Maleate?

Levomepromazine Maleate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Sedation or drowsiness - Orthostatic hypotension - Dry mouth and other anticholinergic effects - Weight gain - Constipation - Blurred vision

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Agranulocytosis or severe leukopenia - Life‑threatening cardiac arrhythmias - Severe hypotension leading to syncope - Seizures - Tardive dyskinesia or other irreversible movement disorders

What precautions apply to Levomepromazine Maleate?

Before initiating therapy, clinicians should consider several safety measures.

- Blood pressure monitoring: watch for orthostatic drops. - Cardiac assessment: evaluate history of arrhythmias or QT prolongation. - CNS depression: avoid in patients with severe respiratory compromise. - Elderly patients: start at lower doses and monitor for falls. - Hepatic/renal function: adjust dosing if impairment is present. - Store at below 25°C: keep in the original pack, protect from moisture.

What does Levomepromazine Maleate interact with?

Levomepromazine Maleate can interact with a variety of medicines, requiring careful management.

Major Interactions (Avoid): - CNS depressants (e.g., opioids, benzodiazepines): increased sedation and respiratory depression. - Antihypertensive agents: additive hypotensive effect. - QT‑prolonging drugs (e.g., certain antiarrhythmics): heightened risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): possible serotonin syndrome. - Alcohol: enhances sedative properties and may worsen hypotension.

Frequently asked questions

What conditions is Levomepromazine Maleate used to treat?+
Levomepromazine Maleate is prescribed for schizophrenia, other psychotic disorders that cause severe agitation, and for intense nausea or vomiting that has not responded to standard antiemetic therapy. It belongs to the phenothiazine antipsychotic class and works across several receptor systems to provide symptom control.
How does Levomepromazine Maleate work in the body?+
The drug blocks dopamine D2 receptors, which reduces psychotic signaling in the brain. It also antagonises histamine H1, muscarinic, adrenergic and serotonergic receptors, contributing to its sedative, antiemetic, and anticholinergic effects. This multi‑receptor activity underlies both its antipsychotic and anti‑nausea actions.
What is the usual dose of Levomepromazine Maleate?+
Dosing of Levomepromazine Maleate is individualized. The prescribing clinician determines the appropriate dose based on the patient’s condition, severity, age, renal and hepatic function, and response to therapy. No fixed regimen is provided here; the prescriber sets the regimen.
Is Levomepromazine Maleate safe during pregnancy or breastfeeding?+
Safety data for Levomepromazine Maleate in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers should assess each case carefully and discuss alternatives when possible.
How do I order Levomepromazine Maleate from GNH USA?+
To request Levomepromazine Maleate, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.
How does Levomepromazine Maleate compare with other antipsychotics?+
Compared with newer atypical antipsychotics, Levomepromazine Maleate has a broader receptor profile, offering strong sedation and antiemetic properties. However, it may carry a higher risk of anticholinergic effects, hypotension and extrapyramidal symptoms. Choice of therapy depends on the clinical scenario, patient tolerance and therapeutic goals.
What are the recommended storage conditions for Levomepromazine Maleate?+
Levomepromazine Maleate should be stored at temperatures below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keeping the product in a dry, cool environment helps maintain its stability and potency.
How is Levomepromazine Maleate administered?+
The medication is supplied as an oral formulation and is taken by mouth. It may be given with or without food, according to the prescriber’s instructions. Patients should follow the dosing schedule provided by their healthcare professional.
What are the most serious risks associated with Levomepromazine Maleate?+
Serious risks include neuroleptic malignant syndrome, agranulocytosis, severe cardiac arrhythmias, profound hypotension, seizures, and irreversible movement disorders such as tardive dyskinesia. Immediate medical attention is required if any of these severe reactions are suspected.
Who should not use Levomepromazine Maleate?+
Levomepromazine Maleate is contraindicated in patients with known hypersensitivity to phenothiazines, those with severe cardiovascular disease prone to arrhythmias, and individuals with a history of neuroleptic malignant syndrome. Caution is also advised for patients with significant hepatic or renal impairment.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Levomepromazine Maleate
Route
Oral Use
Manufacturer
Morningside Healthcare Ltd
Origin
EU

Related products

Levomentis

Levomentis

Levomepromazine Maleate

Hasco-Lek
EU
Levomepromazin Neuraxpharm

Levomepromazin Neuraxpharm

Levomepromazine Maleate

Neuraxpharm Arzneimittel Gmbh
EU
Levomepromazin Terapia

Levomepromazin Terapia

Levomepromazine Maleate

Terapia S.A.
EU
Levorol

Levorol

Levomepromazine Maleate

Galvany Pharma Limited
EU